MARK2 and neoplasm: MiRNA 421 was reported to suppress a serine/threonine kinase, MAPK14, which regulates apoptosis and cell cycle, ultimately suppressing cellular proliferation and tumor formation (Hui et al., 2007; Thornton and Rincon, 2009).